68 results
Page 2 of 4
8-K
EX-99.1
lafvawbu5lmjq 2o
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am
8-K
EX-99.1
k0mz3im0j3li 6skhf
26 Oct 21
Regulation FD Disclosure
11:00am
8-K
EX-99.1
nj70h9zf
19 Oct 21
Regulation FD Disclosure
10:30am
8-K
EX-99.1
dd2w0onm
22 Sep 21
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000
12:52pm
8-K
EX-99.1
wi97mbfd27v
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm
424B3
7b95p39i 7pv
11 May 21
Prospectus supplement
4:27pm
8-K
EX-99.1
rczh0t
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-10.3
hvawlnbp17jvteji u5
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
425
wn0lby3v5y0f54m
13 Apr 21
Business combination disclosure
9:05am
425
oifdu2fb
12 Apr 21
Business combination disclosure
9:21am
425
aoril
22 Mar 21
Business combination disclosure
5:21pm
S-4/A
ui913c
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm